123I-3H11在荷瘤裸鼠体内的SPECT显像

    SPECT Imaging of 123I-3H11 in Tumor-Bearing Nude Mice in Vivo

    • 摘要: 研究了123I标记单克隆抗体3H11在荷瘤裸鼠体内的生物分布和SPECT显像。体内生物学分布显示,肿瘤摄取24h时达最大值(11.06±1.86)%ID/g, 注射123I-3H11 24h T/NT比值分别为:肿瘤/血,2.90±0.06;肿瘤/甲状腺,1.51±0.42;肿瘤/胃,9.96±0.56。注射7.4 MBq 123I-3H11于2、24h行SPECT显像,显像结果表明,24h后能清晰显像。标记抗体的裸鼠体内生物学分布结果与显像结果基本一致。生物分布和显像表明,123I-3H11可能成为一种新的胃癌SPECT显像剂。

       

      Abstract: The biodistribution and SPECT imaging of 123I labeled 3H11(123I-3H11) monclonal antibody in tumor-bearing mice were investigated. The biodistribution results show the uptake rate in the tumor at 24h post-injection with (11.06±1.86)%ID/g. The uptake ratios of tumor to blood, tumor to thyroid, and tumor to stomach are 2.90±0.06, 1.51±0.42, and 9.96±0.56, respectively. SPECT imaging was performed at 2h and 24h post-injection of 7.4MBq 123I-3H11. Clear imaging of tumor is obtained at 24h post-injection. The biodistribution results of labeled antibodies and their imaging rseults are basically identical.The results of biodistribution and SPECT imaging in tumor-bearing mice indicate that 123I-3H11 may be a new promising SPECT tracer for imaging gastric cancer.

       

    /

    返回文章
    返回